ロード中...
Molecular Docking and Dynamic Simulation of AZD3293 and Solanezumab Effects Against BACE1 to Treat Alzheimer's Disease
The design of novel inhibitors to target BACE1 with reduced cytotoxicity effects is a promising approach to treat Alzheimer's disease (AD). Multiple clinical drugs and antibodies such as AZD3293 and Solanezumab are being tested to investigate their therapeutical potential against AD. The curren...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018-06-01
|
| シリーズ: | Frontiers in Computational Neuroscience |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/article/10.3389/fncom.2018.00034/full |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|